QuidelOrtho Receives FDA Clearance for QuickVue COVID-19 Test
QuidelOrtho Secures FDA Approval for QuickVue COVID-19 Test
QuidelOrtho has received FDA 510(k) clearance for its QuickVue COVID-19 test, a pivotal development in the company's ongoing efforts to combat the pandemic. This approval underscores the test's reliability and accuracy in diagnosing COVID-19 infections, providing healthcare professionals and the public with a valuable tool in the battle against the virus.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.